APPLICATION
ANDA076679
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-21
LATEST ACTION
2020-04-06
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · CREAM · TOPICAL
Approval history
2020-04-06Labeling · Supplement 16 · standardAP
2015-07-31Labeling · Supplement 11 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.